Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Captor's CT-01 compounds for HCC shown to induce degradation of GSPT1 and SALL4

April 12, 2022

IMP-2 validated as cancer target, small-molecule inhibitors identified

April 12, 2022

BCAT deletion from T cells may offer advantage to lymphoma immunotherapy

April 12, 2022

Phytos identifies new PD-L1 inhibitors

April 12, 2022

New N-myristoyltransferase inhibitors presented by MyricX Pharma, Imperial Innovations Group

April 12, 2022

Shanghai Hongheng Biomedical Technology divulges anticancer compounds

April 12, 2022

HDAC7 plays a role in glioblastoma multiforme and is a promising therapeutic target

April 11, 2022

Propionate metabolism plays role in metastatic ability

April 11, 2022

Targeting menin-MLL1 interaction inhibits neuroblastoma growth

April 11, 2022

Merck & Co. divulges new ceramide glucosyltransferase inhibitors

April 11, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...